G Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Genpact Ltd is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is trading at a low P/E ratio of 12, the lowest in the past year, and has shown consistent growth in its Advanced Technology Solutions segment. Despite recent price declines, the company's solid Q4 financial performance, positive institutional interest, and attractive valuation make it a compelling long-term investment opportunity.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 59.647, showing no overbought or oversold conditions. However, the moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near resistance levels (R1: 39.476). The stock has a 70% chance to decline by -1.3% in the next day but a 1.19% chance to rise in the next week.
Nalanda India Equity Fund Ltd increased its stake by over 1 million shares, indicating institutional confidence.
Genpact's Advanced Technology Solutions segment is driving growth.
The company reported a 7% YoY revenue increase and a 3.8% YoY EPS growth in Q4
The stock's P/E ratio of 12 is attractive compared to historical levels.
Hedge funds are selling, with an 805.73% increase in selling activity over the last quarter.
The stock has declined 27.3% year-over-year.
Analysts have lowered price targets, with mixed ratings (Buy and Neutral).
In Q4 2025, Genpact reported a 5.65% YoY revenue increase to $1.32 billion, a 0.83% YoY net income increase to $143.09 million, and a 3.8% YoY EPS increase to $0.82. Gross margin improved by 2.33% YoY to 36%. The company is showing steady financial growth.
Analysts have mixed views. Needham maintains a Buy rating but lowered the price target to $50 from $53, citing strong Q4 results and growth in the Advanced Technology Solutions segment. Susquehanna has a Neutral rating with a reduced price target of $42, noting solid execution but slower growth in the core business.
